Company Overview

Hannover Rück SE, together with its subsidiaries, provides reinsurance products and services worldwide. It operates through Property & Casualty Reinsurance, and Life & Health Reinsurance segments. The company offers property, casualty, facultative, catastrophe XL, structured reinsurance, and insurance-linked securities. It also provides risk solutions for agricultural, livestock, and bloodstock businesses; aviation and space business; and marine and offshore energy business, as well as credit, surety, and political risks reinsurance products. In addition, the company offers group and individual credit life, enhanced annuities, group life and health, and Takaful reinsurance products; and risk solutions in the areas of critical illness, disability, health, longevity, long term care, mortality, and morbidity. Further, it provides various financial solutions, including new-business financing; monetization of embedded value; reserve and solvency relief; and divestiture of non-core businesses. The company was formerly known as Hannover Rückversicherung AG and changed its name to Hannover Rück SE in March 2013. The company was founded in 1966 and is headquartered in Hanover, Germany. Hannover Rück SE is a subsidiary of Talanx AG.

  • Name

    Hannover Rück SE

  • CEO

    Mr. Jean-Jacques Henchoz

  • Website

    www.hannover-re.com

  • Sector

    Insurance

  • Year Founded

    1966

Profile

  • Market Cap

    €30.98B

  • EV

    €35.64B

  • Shares Out

    120.6M

  • Revenue

    €25.71B

  • Employees

    3,856

Margins

  • Gross

    10.12%

  • EBITDA

    8.35%

  • Operating

    8.03%

  • Pre-Tax

    8.44%

  • Net

    7.88%

  • FCF

    22.14%

Returns (5Yr Avg)

  • ROA

    1.7%

  • ROTA

    14.47%

  • ROE

    11.26%

  • ROCE

    3.94%

  • ROIC

    2.1%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    €247.33

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    €1,068.6M

  • Net Debt

    €3,823.5M

  • Debt/Equity

    0.43

  • EBIT/Interest

    14.23

Growth (CAGR)

  • Rev 3Yr

    1.78%

  • Rev 5Yr

    5.07%

  • Rev 10Yr

    6.7%

  • Dil EPS 3Yr

    20.77%

  • Dil EPS 5Yr

    11.66%

  • Dil EPS 10Yr

    8.26%

  • Rev Fwd 2Yr

    6.36%

  • EBITDA Fwd 2Yr

  • EPS Fwd 2Yr

    16.05%

  • EPS LT Growth Est

    12.32%

Dividends

  • Yield

  • Payout

    35.72%

  • DPS

    €6

  • DPS Growth 3Yr

    10.06%

  • DPS Growth 5Yr

    9.86%

  • DPS Growth 10Yr

    7.18%

  • DPS Growth Fwd 2Yr

    13.55%

XTRA:HNR1